SavedAdd your journal

Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 1999 / Cilt: 52 - Sayı: 4

Serum IL-6, IL-1alpha, TNFalpha levels in amyloidosis

Amiloidozisde serum IL-6, IL-1alfa, TNFalfa düzeyleri

Sabite KACAR
Oktay KARATAN
Hüseyin TUTKAK
Pages
219–225
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum IL-6 levels in all patients were significantly higher than control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serum interleukin-6 (IL-6) interleukin-1a (IL-l α) tumor necrosis, factor a (TNF α) levels were determined by ELISA in all 32 patients suffering from primary amyloidosis, secondary amyloidosis and amyloidosis due to Familial Mediterranean Fever (FMF) and 20 healthy control group.
📊
Key Findings & Data:Serum interleukin-6 (IL-6) interleukin-1a (IL-l α) tumor necrosis, factor a (TNF α) levels were determined by ELISA in all 32 patients suffering from primary amyloidosis, secondary amyloidosis and amyloidosis due to Familial Mediterranean Fever (FMF) and 20 healthy control group.
💡
Conclusion & Impact:Serum IL-6 levels in all patients were significantly higher than control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serum interleukin-6 (IL-6) interleukin-1a (IL-l α) tumor necrosis, factor a (TNF α) levels were determined by ELISA in all 32 patients suffering from primary amyloidosis, secondary amyloidosis and amyloidosis due to Familial Mediterranean Fever (FMF) and 20 healthy control group. Serum IL-6 levels in all patients were significantly higher than control group (p

Özet

Primer amiloidozis, sekonder amiloidozis, Ailevi Akdeniz Ateşi'ne (FMF) bağlı amiloidozisli toplam 32 hasta ve 20 sağlıklı kontrol grubunda serum interlökin-6 (IL-6), interlökin l α (İL, l α), tümör nekrozis faktör α (TNF α) düzeylerini ELISA yöntemiyle tayin ettik. Tüm hastalarda IL-6 düzeyleri kontrol grubuna göre (p

🔖

Cite This Article

KACAR, S., KARATAN, O., TUTKAK, H. (2022). Serum IL-6, IL-1alpha, TNFalpha levels in amyloidosis. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 52 - Sayı: 4, 219–225. https://ajindex.com/articles/444244

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Massry SC, Glassock RJ. Textbook of Nephrology. Baltimore 1989; Williams Wilkins: 745-746
  2. Glassock RJ, Cohen AS, Adler SG ve ark. Seconder glomerular diseases in The Kidney Brenner B, Rector F. 1991; 1280-1368
  3. Stone M. Amyloidosis: A final common pathvvay for protein deposition in tissues. Blood 1990; 75, 3: 531-545
  4. Finn A, Peter D, Gorevic MD.Clinical and biochemical correlates in primary amyloidosis. Am J Clin Pathol 1990; Sep. 353-355
  5. Glenner GG. Amyloid deposits and amyloidosis; the b fibrilloses. N Engl J Med 1980; 302: 1283-1292, 1333-1343
  6. Havvkins PN, Lavander JP, Pepys MB.Evaluation of systemic amyloidosis by scintgrapy vvith 123 l labeled serum amyloid P component. N Engl J Med 1990; Aug, 23:508-513
  7. Catchcart ES, Skinner M, Cohen AS.Immunogenicity of amyloid. Immunology 1971; 20: 945-954
  8. Nakayama T, Satomi S, Takashi U. Monitoring both serum amyloid protein A and CRP as inflammatory markers in infectious diseases. Clin Chem 1993; 39, 2:293-297
  9. Kushner I, Ganapath MK, Mac.lntyre. Regulation of biosyntesis and secretion of human CRP and SAA. In acute phase proteins in the acute phase response. Pepys Springer-Verlag, Londan: 1989; 69-83
  10. Ramadori G, Sipe SD, Colten HR. Expression and regulation of the murine SAA gen in extrahepatik sites. J Immunol 1985; 135: 3645-3647
  11. Abul K. Abbas, Lichtman AH, Pober TS. Cellular and molecular immunology. 1991; Philadelphia: Saunders Company, 226-242
  12. Arai K, Miyojima A, Miyatakes S, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem 1990; 59: 783-836
  13. Benson MD, Scheinberg MA, Shiroma T. Kinetics of serum amyloid protein A in case in induced murine amyloidosis. J Clin Invest 1977; 59: 412-416
  14. Dovvton B, Peters CN, Jestus JJ. Regulation of SAA gen expression in Syrian hamsters my cytokines. Inflammation 1991; 15, 5: 391-397
  15. Brissette L, Young I, Narindra SS. Differential induction of SAA gen family in response to an inflammatory agent and amyloid enhancing factor. J Biol Chem 1989; 264, 32: 19327-19323
  16. Beutler B, Cerami A. The biology of cachectin - TNF a. A primary mediator of the host response. Ann Rev Immunol 1988; 7: 625-655
  17. Andes T, Geiger T, Hirano T. Action of rh IL-6, IL-1 b and TNFa on mRNA induction of acute phase proteins. Eur J Immunol 1988; 18: 739-746
  18. Cohen AS, Shirahama JD. Amyloid proteins, precursors, mediator, enhancer. Lab Invest 1983; 48: 1-6
  19. Meyerhoff J. FMF. Medicine 1980; 59: